Corporate
Governance

TransMed7, LLC is a privately held Limited Liability Corporation, organized in the State of Delaware in 2010.  As such, it is managed by the Chief Executive Officer, reporting to the governing Board of Directors of the Company.  Powers of the Manager and Powers Reserved to the Board are as outlined in the Operating Agreement of the Company, as ratified by the Members of the Company.

Additionally, TransMed7 maintains close ties with several key industry leaders of independent medical device corporations and other organizations as periodic Board Advisors to provide strategic guidance to the Board when needed.

TransMed Bird Organe

TransMed7’s Corporate
Governance Team

TransMed7 is dedicated to maintaining the highest ethical standards
in all of its business operations and communications.

TransMed7’s independent tax advisory and auditing firm is Aronson, LLC.

Board of Directors

James W. Vetter

TransMed7 Co-Founder & Chairman

Chairman of the Board

Jack W. Cumming

Board Member

Member of the Board

Eugene H. Vetter

TransMed7 Co-Founder & CEO

Chief Executive Officer, TransMed7, LLC

Jeffrey C. Coyne

Legal Counsel

General Counsel, Transmed7, LLC

Tracy A. Sykes

Board Member

Member of the Board

John B. Simpson

MD, PhD

Strategic Advisor to the Board

Business Advisory Board

TransMed7’s Business Advisory Board is a body that provides strategic advice to the CEO and President of TransMed7, LLC.  Its principal function is to offer assistance to TransMed7’s senior management team by providing high-quality advice and networking in TransMed7’s industry.

The TransMed7 Business Advisory Board is composed of accomplished experts offering innovative advice and dynamic perspectives that will contribute to the accomplishment of TransMed7’s tactical goals and strategic objectives.  These business experts represent a carefully selected group of proven innovators, each of whom has already established his or her reputation based on high ethical standards, demonstrated leadership, and a willingness to embrace and support a mission for the good of others.  The Members of the Business Advisory Board provide TransMed7’s Senior Management Team with expanded business perspectives in a constantly changing environment, and each Member brings a focus and particular emphasis on one or more of a number of business sectors, including but not limited to the following areas:

  • Strategic Planning, including Tactical Execution;
  • Commercial Launch of new Platform Technologies;
  • U.S. and O.U.S.-based Distributors and Sales Networks;
  • Corporate Relations Analysis and Development;
  • International Business Management and Strategic Market Development;
  • Financial Management, Fundraising and Investment Performance Options;
  • Corporate Compliance and Tax Planning Advice; and
  • Public Relations, Networking, Communications and Advocacy.

The members of TransMed7’s Business Advisory Board are listed as follows:

Eugene H. Vetter

TransMed7 Co-Founder & CEO

Chairman

Mark A. Bradley

Board Member

Business Advisory Board

Michael J. Cyrus

Board Member

Business Advisory Board

Jerry Turin

Board Member

Business Advisory Board

Edgar D. Staren

MD, PhD, MBA

Executive Chairman

Carlos Collazo

Board Member

Business Advisory Board

Carin Fradin

Board Member

Business Advisory Board

Tony M. Astorga

Board Member

Business Advisory Board

Thomas Cowan

Board Member

Business Advisory Board

David P. Harding

Board Member

Business Advisory Board

Want to Know More?

For further information on TransMed7 and its platform technologies,
please reach out to us using the form below.